Active Immunotherapy for Glioblastoma Treatment: A Systematic Review and Meta-Analysis

• Main Authors: Joni Wahyuhadi, Joni, Irwan Barlian Immadoel Haq, Irwan, Muhammad Reza Arifianto, Muhammad, Bagus Sulistyono, Bagus, Rizki Meizikri, Rizki, Atika Rosada, Atika, Cita Rosita Sigit Prakoeswa, Cita, Rahadian Indarto Susilo, Rahadian
• Format: Article PeerReviewed
• Language: English; English; English; English
• Published: Moffitt Cancer Center
• Subjects: R5-920 Medicine (General)
• Online Access: https://repository.unair.ac.id/120032/1/04.%20Artikel.pdf; https://repository.unair.ac.id/120032/2/04.%20turnitin.pdf; https://repository.unair.ac.id/120032/4/04.%20Active%20Immunotherapy%20Treatment%20for%20Glioblastoma.pdf; https://repository.unair.ac.id/120032/8/04.%20karil.pdf; https://repository.unair.ac.id/120032/; https://journals.sagepub.com/doi/full/10.1177/10732748221079474
• Institution: Universitas Airlangga

Abstract Introduction Glioblastoma multiforme (GBM) makes 60–70% of gliomas and 15% of primary brain tumors. Despite the availability of standard multimodal therapy, 2 years, 3 years, and 5 years survival rate of GBM are still low. Active immunotherapy is a relatively new treatment option for GBM...